Document Classification

Section Type: RESULTS

Text: The intent-to-treat objective response rate was 14. 3 % in arm A and 11. 6 % in arm B. Median duration of response was 8. 7 months (95 % CI, 5. 3 to 9. 5 months) in arm A and 9. 6 months (95 % CI, 6. 1 to 19. 7 months) in arm B. Median time to progression was 2. 1 months (95 % CI, 1. 4 to 2. 8 months) for arm A and 1. 5 months (95 % CI, 1. 4 to 2. 8 months) for arm B. Median survival was 8. 3 months (95 % CI, 5. 8 to 11. 5 months) for arm A, and 7. 3 months (95 % CI, 5. 7 to 11. 7 months) for arm B ; the 1-year survival rate (both cohorts) was 38 %.